Treatment of disorders secondary to organic impairments
US6323242A · kind A · utility
20Cited by
23References
17Claims
0Family size
Inventor
Key dates
| Filing date | Dec 2, 1998 |
| Grant date | Nov 27, 2001 |
| Priority date | — |
| Expiry date | Dec 2, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P31/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treatment of neuropsychiatric symptoms or disorders emanating from primary brain or systemic impairments includes administration of an effective dose of a dopamine, serotonin, and norepinephrine reuptake inhibitor to a human in need of such treatment. The preferred reuptake inhibitor is sibutramine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.